Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TGF-beta in kidney fibrosis: a target for gene therapy.

× No keyword cloud information.

77 in total

1. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.

Authors: T Wyss-Coray; C Lin; D A Sanan; L Mucke; E Masliah
Journal: Am J Pathol Date: 2000-01 Impact factor: 4.307

2. Transforming growth factor beta contributes to progressive diabetic nephropathy.

Authors: W B Reeves; T E Andreoli
Journal: Proc Natl Acad Sci U S A Date: 2000-07-05 Impact factor: 11.205

3. Pathogenesis of renal injury in the megabladder mouse: a genetic model of congenital obstructive nephropathy.

Authors: Susan E Ingraham; Monalee Saha; Ashley R Carpenter; Melissa Robinson; Ihab Ismail; Sunita Singh; David Hains; Michael L Robinson; Daniel A Hirselj; Stephen A Koff; Carlton M Bates; Kirk M McHugh
Journal: Pediatr Res Date: 2010-12 Impact factor: 3.756

Review 4. The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.

Authors: Jennifer M Sasser
Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-07-24 Impact factor: 3.619

5. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.

Authors: Yingjian Li; Xiaoyan Wen; Bradley C Spataro; Kebin Hu; Chunsun Dai; Youhua Liu
Journal: J Am Soc Nephrol Date: 2005-11-16 Impact factor: 10.121

6. Nanolayered siRNA delivery platforms for local silencing of CTGF reduce cutaneous scar contraction in third-degree burns.

Authors: Steven A Castleberry; Alexander Golberg; Malak Abu Sharkh; Saiqa Khan; Benjamin D Almquist; William G Austen; Martin L Yarmush; Paula T Hammond
Journal: Biomaterials Date: 2016-04-14 Impact factor: 12.479

7. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.

Authors: Jinhua Li; Naomi Vittoria Campanale; Rong Jiao Liang; James Antony Deane; John Frederick Bertram; Sharon Denise Ricardo
Journal: Am J Pathol Date: 2006-11 Impact factor: 4.307

8. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts.

Authors: Adam C Midgley; Mathew Rogers; Maurice B Hallett; Aled Clayton; Timothy Bowen; Aled O Phillips; Robert Steadman
Journal: J Biol Chem Date: 2013-04-15 Impact factor: 5.157

9. Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy.

Authors: Aysun K Bayazit; Yildirim Bayazit; Aytul Noyan; Gulfiliz Gonlusen; Ali Anarat
Journal: Pediatr Nephrol Date: 2003-01-10 Impact factor: 3.714

10. The inhibitory effect of siRNAs on the high glucose-induced overexpression of TGF-beta1 in mesangial cells.

Authors: Hey-Jeong Noh; Hyun-Chul Kim; Sang-Sook Lee; Yu-Na Kang; Young-Mi Chae; Kwan-Kyu Park
Journal: J Korean Med Sci Date: 2006-06 Impact factor: 2.153